Form 4 for DGX Quest Diagnostics
Accepted 2022-11-29 00:00:00 ET · period of report 2022-11-28 · accession 0001022079-22-000168 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-11-29 | 2022-11-28 | DGX | Doherty Catherine T. | SVP, Regional Businesses | M - OptEx | $86.63 | +40.8K | 108.5K | +60% | +$3.53M |
| DM | 2022-11-29 | 2022-11-28 | DGX | Doherty Catherine T. | SVP, Regional Businesses | S - Sale+OE | $149.18 | -40.8K | 91.1K | -31% | -$6.08M |
| D | 2022-11-29 | 2022-11-28 | DGX | Doherty Catherine T. | SVP, Regional Businesses | M - OptEx | $86.63 | -40.8K | 0 | -100% | -$3.53M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-11-28 | M | A | 40,765 | $86.63 | 108,498 | D | — | — | |
| 2 | Common | Common Stock | 2022-11-28 | S | D | 23,407 | $149.37 | 67,733 | D | — | — | (F3) This transaction was executed in multiple trades at prices ranging from $149.120 to $149.860. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 3 | Common | Common Stock | 2022-11-28 | S | D | 17,358 | $148.92 | 91,140 | D | — | — | (F2) This transaction was executed in multiple trades at prices ranging from $148.120 to $149.110. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. |
| 4 | Derivative | Non-Qualifed Stock Option (right to buy) | 2022-11-28 | M | D | 40,765 | $86.63 | 0 | D | $86.63 · — to 2029-02-18 | 40,765 Common Stock | (F5) The options vested in three annual installments beginning with the first on February 18, 2020, the second on February 18, 2021 and the final on February 18, 2022. |